GeoWealth Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.23M Sell
9,381
-508
-5% -$106K 0.07% 160
2026
Q1
$2.09M Sell
9,889
-467
-5% -$101K 0.08% 157
2025
Q4
$2.13M Buy
10,356
+4,488
+76% +$845K 0.08% 153
2025
Q3
$921K Sell
5,868
-10,052
-63% -$1.55M 0.03% 319
2025
Q2
$2.67M Buy
15,920
+856
+6% +$127K 0.1% 115
2025
Q1
$2.08M Buy
15,064
+10,712
+246% +$1.37M 0.08% 141
2024
Q4
$515K Sell
4,352
-213
-5% -$24.9K 0.02% 458
2024
Q3
$505K Sell
4,565
-304
-6% -$31.8K 0.02% 469
2024
Q2
$479K Buy
4,869
+1,983
+69% +$202K 0.02% 442
2024
Q1
$323K Buy
+2,886
New +$311K 0.01% 555

Other funds holding CAH

GeoWealth Management's CAH Position: Q2 2026 in Review

GeoWealth Management reduced its Cardinal Health (CAH) stake by 5.1% in Q2 2026, selling an estimated $106K and leaving 9,381 shares worth $2.23M. The position accounts for 0.07% of the portfolio, ranked #160.

GeoWealth Management first reported a position in CAH in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.67M in Q2 2025. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • GeoWealth Management held 9,381 shares of Cardinal Health worth $2.23M as of Q2 2026.
  • GeoWealth Management sold 508 Cardinal Health shares in Q2 2026, an estimated $106K.
  • Cardinal Health made up 0.07% of GeoWealth Management's portfolio in Q2 2026, its #160 holding.
  • GeoWealth Management first reported a position in Cardinal Health in Q1 2024 and has held it in 10 quarters since.
  • GeoWealth Management's Cardinal Health position peaked at $2.67M in Q2 2025.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on GeoWealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.